FDA product code OOI: Real Time Nucleic Acid Amplification System

OOI is the FDA product code for real time nucleic acid amplification system. It is a Class II device, regulated under 21 CFR 862.2570 and reviewed by the Clinical Chemistry panel. FDA has cleared 14 510(k) submissions under OOI, 3 in the last five years, from 10 different applicants. The average 510(k) review took 106 days (median 88); 90 days on average over the last three years. FDA has posted 30 recalls for OOI devices, 16 initiated in the last five years.

Definition

The system is a clinical multiplex instrument intended to measure and sort multiple signals generated my multiple probes, intercalating dyes, or other ligands in an assay from a clinical sample. Signals may be generated by fluorescence or other phenomena and may be measured using filters on a photodiode or other detector. It may integrate sample and/or reagent handling, amplification, dedicated instrument control, data acquisition software, raw data storage mechanisms and other essential hardware components along with the signal reader unit. The system is used with specific assays to comprise an assay test system.

Classification

FieldValue
Device nameReal Time Nucleic Acid Amplification System
Device classClass II
Regulation21 CFR 862.2570
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k) exempt

510(k) clearances per year for OOI

YearClearancesAvg. review days
2017190
20221143
20231134
2025190

Compare with all 510(k) review times · Search every OOI clearance

Top OOI applicants

ApplicantClearancesLatest
Meridian Bioscience, Inc.32025-03-20
Luminex Corporation32016-06-30
Genepoc, Inc.12017-05-25
Alere Scarborough, Inc.12015-07-16
Becton, Dickinson and Company12014-05-20

5 more applicants have OOI clearances. See the full list in Caduvo.

Most recent OOI clearances

510(k)ApplicantDeviceDecision dateReview days
K243922Meridian Bioscience, Inc.Revogene2025-03-2090
K222779Meridian Bioscience, Inc.Revogene2023-01-26134
K220480Meridian Bioscience, Inc.Revogene2022-07-11143
K170558Genepoc, Inc.revogene2017-05-2590
K161495Luminex CorporationARIES MI System, ARIES HSV 1&2 Assay Cassettes-Carton of 24 (IVD), ARIES HSV 1&2 Assay Protocol File Kit (IVD)2016-06-3029

Recalls for OOI devices

30 product recalls in 30 recall events; 16 initiated in the last five years and 15 still open. Most recent: 2025-03-20.

YearRecalls
20171
20181
20191
20201
20214
20227
20232
20243
20251

Frequently asked questions

What is FDA product code OOI?

OOI is the FDA product code for real time nucleic acid amplification system. It is a Class II device, regulated under 21 CFR 862.2570 and reviewed by the Clinical Chemistry panel.

What device class is OOI?

Class II, regulation 21 CFR 862.2570. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code OOI?

Across 14 cleared submissions the average was 106 days from receipt to decision (median 88).

Which companies have the most OOI clearances?

Meridian Bioscience, Inc. (3); Luminex Corporation (3); Genepoc, Inc. (1); Alere Scarborough, Inc. (1); Becton, Dickinson and Company (1).

Have OOI devices been recalled?

Yes: 30 product recalls across 30 recall events; the most recent began 2025-03-20.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times